Furthermore, we identified aberrant expression of IRX2, IRX3 and MEIS1 in patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) which originates from early B-cell progenitors. Here, MEIS1 is linked to precursor B-cell acute lymphoblastic leukemia.